Related Experiment Video
Updated: Jun 3, 2026

11:44
Generation of a Humanized Mouse Liver Using Human Hepatic Stem Cells
Published on: August 29, 2016
Generation and characterization of a humanized PPARδ mouse model
B Gross1, N Hennuyer, E Bouchaert
1Université Lille Nord de France, Lille, France.
British Journal of Pharmacology
|March 24, 2011
Summary
Humanized mice expressing human peroxisome proliferator-activated receptor delta (PPARδ) showed similar lipid metabolism and anti-inflammatory responses compared to wild-type mice. This PPARδ knock-in model is valuable for preclinical assessment of PPARδ activator drugs.
Area of Science:
- Pharmacology
- Metabolic Diseases
- Immunology
Background:
- The nuclear receptor peroxisome proliferator-activated receptor delta (PPARδ) plays a role in lipid metabolism and inflammation.
- Understanding species-specific differences in PPARδ function is crucial for drug development.
Purpose of the Study:
- To generate humanized mice for PPARδ (PPARδ KI mice) to investigate functional differences between mouse and human PPARδ.
- To assess the utility of PPARδ KI mice for early drug efficacy assessment.
Main Methods:
- Human PPARδ function was evaluated in PPARδ KI mice under various conditions, including fasting and challenge with the GW0742 compound.
- Mice were fed either a chow diet or a high-fat diet (HFD).
- Gene expression profiling was performed in liver, muscle, and macrophages.
Main Results:
- PPARδ KI mice exhibited hypomorphic expression of human PPARδ in several tissues, with minor effects on lipid parameters.
- Plasma metabolic parameters and responses to fasting or GW0742 treatment were similar between PPARδ KI and wild-type mice.
- Gene expression patterns regulated by human and mouse PPARδ were comparable, as was the anti-inflammatory potential.
Conclusions:
- Human PPARδ can effectively compensate for mouse PPARδ in regulating lipid metabolism and inflammation.
- The PPARδ KI mouse model demonstrates responsiveness to pharmacological challenges and is a useful tool for preclinical evaluation of PPARδ activators.
